150 related articles for article (PubMed ID: 15938591)
21. Patterns of food and acid reflux in patients with low-grade oesophagitis--the role of an anti-reflux agent.
Washington N; Steele RJ; Jackson SJ; Washington C; Bush D
Aliment Pharmacol Ther; 1998 Jan; 12(1):53-8. PubMed ID: 9692701
[TBL] [Abstract][Full Text] [Related]
22. An alginate-antacid formulation (Gaviscon Double Action Liquid) can eliminate or displace the postprandial 'acid pocket' in symptomatic GERD patients.
Kwiatek MA; Roman S; Fareeduddin A; Pandolfino JE; Kahrilas PJ
Aliment Pharmacol Ther; 2011 Jul; 34(1):59-66. PubMed ID: 21535446
[TBL] [Abstract][Full Text] [Related]
23. Effect of time of dosing relative to a meal on the raft formation of an anti-reflux agent.
Washington N; Greaves JL; Wilson CG
J Pharm Pharmacol; 1990 Jan; 42(1):50-3. PubMed ID: 1969950
[TBL] [Abstract][Full Text] [Related]
24. Randomised clinical trial: sodium alginate oral suspension is non-inferior to omeprazole in the treatment of patients with non-erosive gastroesophageal disease.
Chiu CT; Hsu CM; Wang CC; Chang JJ; Sung CM; Lin CJ; Chen LW; Su MY; Chen TH
Aliment Pharmacol Ther; 2013 Nov; 38(9):1054-64. PubMed ID: 24024757
[TBL] [Abstract][Full Text] [Related]
25. [Influence of sodium alginate on the intestinal transit in low birth weight newborn infants].
Chouraqui JP; Morer I; Renard P; Bielsky MC; Richard-Berthe C; Rambaud P
Pediatrie; 1993; 48(6):473-7. PubMed ID: 8247649
[TBL] [Abstract][Full Text] [Related]
26. Rapid onset of effect of sodium alginate on gastro-oesophageal reflux compared with ranitidine and omeprazole, and relationship between symptoms and reflux episodes.
Dettmar PW; Sykes J; Little SL; Bryan J
Int J Clin Pract; 2006 Mar; 60(3):275-83. PubMed ID: 16494641
[TBL] [Abstract][Full Text] [Related]
27. Gastro-oesophageal reflux. Issues in clinical practice.
Mir NA
BMJ; 2010 Sep; 341():c5158. PubMed ID: 20861111
[No Abstract] [Full Text] [Related]
28. [Diagnostic value of alginate test in gastroesophageal reflux disease].
Bordin DS; Masharova AA; Droxzdov VN; Firsova LD; Kozhurina TS
Eksp Klin Gastroenterol; 2010; (12):102-7. PubMed ID: 21560632
[TBL] [Abstract][Full Text] [Related]
29. The mode of action alginic acid compound in the reduction of gastroesophageal reflux.
Malmud LS; Charkes ND; Littlefield J; Reilley J; Stern H; Rosenberg R; Fisher RS
J Nucl Med; 1979 Oct; 20(10):1023-8. PubMed ID: 231639
[TBL] [Abstract][Full Text] [Related]
30. An investigation into the effect of cimetidine pre-treatment on raft formation of an anti-reflux agent.
Washington N; Wilson CG; Williams DL; Robertson C
Aliment Pharmacol Ther; 1993 Oct; 7(5):553-9. PubMed ID: 8280824
[TBL] [Abstract][Full Text] [Related]
31. The efficacy of sodium alginate (Gaviscon) for the treatment of gastro-oesophageal reflux in preterm infants.
Corvaglia L; Aceti A; Mariani E; De Giorgi M; Capretti MG; Faldella G
Aliment Pharmacol Ther; 2011 Feb; 33(4):466-70. PubMed ID: 21158879
[TBL] [Abstract][Full Text] [Related]
32. Randomised clinical trial: the effectiveness of Gaviscon Advance vs non-alginate antacid in suppression of acid pocket and post-prandial reflux in obese individuals after late-night supper.
Deraman MA; Abdul Hafidz MI; Lawenko RM; Ma ZF; Wong MS; Coyle C; Lee YY
Aliment Pharmacol Ther; 2020 Jun; 51(11):1014-1021. PubMed ID: 32343001
[TBL] [Abstract][Full Text] [Related]
33. Echo-planar magnetic resonance imaging of Gaviscon alginate rafts in-vivo.
Marciani L; Little SL; Snee J; Coleman NS; Tyler DJ; Sykes J; Jolliffe IG; Dettmar PW; Spiller RC; Gowland PA
J Pharm Pharmacol; 2002 Oct; 54(10):1351-6. PubMed ID: 12396296
[TBL] [Abstract][Full Text] [Related]
34. The suppression of gastro-oesophageal reflux by alginates.
Dettmar PW; Hampson FC; Taubel J; Lorch U; Johnstone LM; Sykes J; Berry PJ
Int J Clin Pract; 2007 Oct; 61(10):1654-62. PubMed ID: 17681004
[TBL] [Abstract][Full Text] [Related]
35. Efficacy, safety, and cost issues in managing patients with gastroesophageal reflux disease.
Garnett WR
Am J Hosp Pharm; 1993 Apr; 50(4 Suppl 1):S11-8. PubMed ID: 8097363
[TBL] [Abstract][Full Text] [Related]
36. Gaviscon® vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial.
Pouchain D; Bigard MA; Liard F; Childs M; Decaudin A; McVey D
BMC Gastroenterol; 2012 Feb; 12():18. PubMed ID: 22361121
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of action, efficacy, and onset dynamics of a single dose of alginates in patients with heartburn and GERD].
Bordin DS; Masharova AA; Firsova LD; Kozhurina TS; Safonova OV
Eksp Klin Gastroenterol; 2009; (4):77-85. PubMed ID: 19960998
[TBL] [Abstract][Full Text] [Related]
38. [Restoration of the quality of life by eliminating and prevention of heartburn by alginate: results of multicenter study "VIA APIA"].
Lazebnik LB; Bordin DS; Masharova AA; Dzhulaĭ GS; Butov MA; Abdulkhakov RA; Eremina EIu; Tarasova LV; Safonova OV; Firsova LD; Kozhurina TS
Eksp Klin Gastroenterol; 2010; (6):70-6. PubMed ID: 20731169
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of alginate-based reflux suppressant and magnesium-aluminium antacid gel for treatment of heartburn in pregnancy: a randomized double-blind controlled trial.
Meteerattanapipat P; Phupong V
Sci Rep; 2017 Mar; 7():44830. PubMed ID: 28317885
[TBL] [Abstract][Full Text] [Related]
40. An evaluation of the antireflux properties of sodium alginate by means of combined multichannel intraluminal impedance and pH-metry.
Zentilin P; Dulbecco P; Savarino E; Parodi A; Iiritano E; Bilardi C; Reglioni S; Vigneri S; Savarino V
Aliment Pharmacol Ther; 2005 Jan; 21(1):29-34. PubMed ID: 15644042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
